86
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of DNA damage induced by norcantharidin in human cultured lymphocytes

, , &
Pages 303-306 | Received 11 Apr 2015, Accepted 26 Oct 2015, Published online: 24 Nov 2015

References

  • Al-Sweedan SA, Khabour O, Isam R. (2012). Genotoxicity assessment in patients with thalassemia minor. Mutat Res 744:167–171.
  • Alsatari ES, Azab M, Khabour OF, et al. (2012). Assessment of DNA damage using chromosomal aberrations assay in lymphocytes of waterpipe smokers. Int J Occup Med Environ Health 25:218–224.
  • Alzoubi K, Khabour O, Hussain N, et al. (2012). Evaluation of vitamin B12 effects on DNA damage induced by pioglitazone. Mutat Res 748:48–51.
  • Alzoubi K, Khabour O, Khader M, et al. (2014). Evaluation of vitamin B12 effects on DNA damage induced by paclitaxel. Drug Chem Toxicol 37:276–280.
  • An WW, Wang MW, Tashiro S, et al. (2004). Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways. J Korean Med Sci 19:560–566.
  • Azab M, Khabour OF, Al-Omari L, et al. (2009). Effect of every-other-day fasting on spontaneous chromosomal damage in rat’s bone-marrow cells. J Toxicol Environ Health A 72:295–300.
  • Chang C, Zhu YQ, Mei JJ, et al. (2010). Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells. J Exp Clin Cancer Res 29:145.
  • Chen YN, Chen JC, Yin SC, et al. (2002). Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Int J Cancer 100:158–165.
  • Deng LP, Dong J, Cai H, Wang W. (2013). Cantharidin as an antitumor agent: a retrospective review. Curr Med Chem 20:159–166.
  • Hsieh CH, Chao KS, Liao HF, Chen YJ. (2013). Norcantharidin, derivative of cantharidin, for cancer stem cells. Evid Based Complement Alternat Med 2013:838651.
  • Huan SK, Lee HH, Liu DZ, et al. (2006). Cantharidin-induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell line. Toxicology 223:136–143.
  • Huang Y, Liu Q, Liu K, et al. (2009). Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology 59:209.
  • Jacobson-Kram D, Albertini RJ, Branda RF, et al. (1993). Measurement of chromosomal aberrations, sister chromatid exchange, hprt mutations, and DNA adducts in peripheral lymphocytes of human populations at increased risk for cancer. Environ Health Perspect 101:121–125.
  • Khabour OF, Alawneh K, Al-Kofahi E, Mesmar F. (2014a). Assessment of genotoxicity associated with Behcet’s disease using sister-chromatid exchange assay: vitamin E versus mitomycin C. Cytotechnology 67:1051–1057.
  • Khabour OF, Alsatari ES, Azab M, et al. (2011). Assessment of genotoxicity of waterpipe and cigarette smoking in lymphocytes using the sister-chromatid exchange assay: a comparative study. Environ Mol Mutagen 52:224–228.
  • Khabour OF, Alzoubi KH, Mfady DS, et al. (2014b). Tempol protects human lymphocytes from genotoxicity induced by cisplatin. Int J Clin Exp Med 7:982–988.
  • Khabour OF, Saleh N, Alzoubi KH, et al. (2013). Genotoxicity of structurally related copper and zinc containing Schiff base complexes. Drug Chem Toxicol 36:435–442.
  • Kok SH, Hong CY, Kuo MY, et al. (2003). Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes. Oral Oncol 39:19–26.
  • Krishnan B, Morgan GJ. (2007). Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev 16:377–380.
  • Li Y, Ge Y, Liu FY, et al. (2012). Norcantharidin, a protective therapeutic agent in renal tubulointerstitial fibrosis. Mol Cell Biochem 361:79–83.
  • Liu D, Shi P, Yin X, et al. (2012). Effect of norcantharidin on the human breast cancer Bcap-37 cells. Connect Tissue Res 53:508–512.
  • Ludwig LB, Valiati VH, Palazzo RP, et al. (2013). Chromosome instability and oxidative stress markers in patients with ataxia telangiectasia and their parents. Biomed Res Int 2013:762048.
  • Maluf SW, Marroni NP, Heuser VD, Pra D. (2013). DNA damage and oxidative stress in human disease. Biomed Res Int 2013:696104.
  • Peng F, Wei YQ, Tian L, et al. (2002). Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. J Cancer Res Clin Oncol 128:223–230.
  • Puerto Galvis CE, Vargas Méndez LY, Kouznetsov VV. (2013). Cantharidin-based small molecules as potential therapeutic agents. Chem Biol Drug Des 82:477–499.
  • Rauh R, Kahl S, Boechzelt H, et al. (2007). Molecular biology of cantharidin in cancer cells. Chin Med 2:8.
  • Sadiq MF, Khabour OF, el-Shanti HE, Samawi HM. (2000). The effect of trifluoperazine on the genotoxicity of bleomycin in cultured human lymphocytes. Drug Chem Toxicol 23:361–369.
  • Saleh N, Khabour OF, Esmadi FT, Al-Kofahi E. (2011). In vivo cytogenetic studies on rat’s bone-marrow cells of structurally related Schiff base complexes. Drug Chem Toxicol 34:92–99.
  • Shen B, He PJ, Shao CL. (2013). Norcantharidin induced DU145 cell apoptosis through ROS-mediated mitochondrial dysfunction and energy depletion. PLoS One 8:e84610.
  • Wilson DM III, Thompson LH. (2007). Molecular mechanisms of sister-chromatid exchange. Mutat Res 616:11–23.
  • Yu CC, Ko FY, Yu CS, et al. (2012). Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells. Int J Oncol 41:1050–1060.
  • Zhao Q, Qian Y, Li R, et al. (2012). Norcantharidin facilitates LPS-mediated immune responses by up-regulation of AKT/NF-κB signaling in macrophages. PLoS One 7:e44956.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.